Free Trial

National Research Co. (NASDAQ:NRC) Shares Acquired by Renaissance Technologies LLC

National Research logo with Business Services background

Renaissance Technologies LLC increased its holdings in National Research Co. (NASDAQ:NRC - Free Report) by 6.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 404,886 shares of the company's stock after purchasing an additional 25,002 shares during the period. Renaissance Technologies LLC owned approximately 1.72% of National Research worth $7,142,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. PNC Financial Services Group Inc. lifted its position in shares of National Research by 2,250.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company's stock worth $27,000 after purchasing an additional 1,463 shares during the period. KLP Kapitalforvaltning AS purchased a new stake in National Research in the 4th quarter worth $50,000. FMR LLC lifted its holdings in National Research by 397.3% in the 3rd quarter. FMR LLC now owns 2,944 shares of the company's stock worth $67,000 after purchasing an additional 2,352 shares in the last quarter. Signaturefd LLC lifted its stake in National Research by 613.3% in the 4th quarter. Signaturefd LLC now owns 4,173 shares of the company's stock worth $74,000 after purchasing an additional 3,588 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its position in shares of National Research by 219.3% during the fourth quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company's stock valued at $88,000 after purchasing an additional 3,438 shares in the last quarter. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Price Performance

NRC traded up $0.06 during trading hours on Thursday, hitting $10.69. The company's stock had a trading volume of 6,722 shares, compared to its average volume of 93,152. The business's 50-day moving average price is $13.61 and its 200-day moving average price is $16.68. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 12 month low of $9.76 and a 12 month high of $35.81. The stock has a market cap of $245.18 million, a price-to-earnings ratio of 10.10 and a beta of 0.41.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 4.49%. The ex-dividend date was Friday, March 28th. National Research's dividend payout ratio (DPR) is presently 45.71%.

National Research Company Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Recommended Stories

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Should You Invest $1,000 in National Research Right Now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines